Welcome to our dedicated page for Agilent Technologies SEC filings (Ticker: A), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Agilent Technologies Inc. filings document financial reporting and governance matters for an analytical and clinical laboratory technology company. Form 8-K reports include quarterly financial-result releases, Regulation FD disclosures, non-GAAP measure explanations, executive officer transitions, compensatory arrangements and amendments to charter and bylaws.
Proxy and annual-meeting filings cover director elections, stockholder voting, executive compensation, equity awards and the phased declassification of the board. The records also identify governance changes tied to the company’s Delaware certificate of incorporation and bylaws, together with furnished press releases and related exhibits.
Agilent Technologies Senior Vice President Jonah Prevost Kirkwood reported a small, routine share disposition related to taxes on equity compensation. He surrendered 30 shares of common stock to Agilent at $136.01 per share to cover the tax liability on vesting restricted stock units under Rule 16b-3. Following this tax-withholding transaction, he directly holds 14,108 shares of Agilent common stock.
Agilent Technologies has closed a private sale of $600 million in 4.900% Senior Notes due 2032 to qualified institutional buyers under Rule 144A and to non-U.S. investors under Regulation S. The notes priced at 99.968% of principal, mature on January 15, 2032 and pay interest semi-annually each January 15 and July 15, starting in 2027.
The notes are senior unsecured obligations and can be redeemed early at a make-whole premium before December 15, 2031, and at par plus interest on or after that date. If a Change of Control Repurchase Event occurs, Agilent must offer to repurchase the notes at 101% of principal plus interest.
Under a Registration Rights Agreement, Agilent will use commercially reasonable efforts to exchange the notes for registered notes or, if needed, register resales. If it does not meet these registration obligations by June 25, 2027 or a registration default continues, the notes’ interest rate will increase by up to 0.50% per year until cured.
AGILENT TECHNOLOGIES, INC. executive Timothy Charles Downs, the VP and Chief Accounting Officer, has filed an initial ownership report showing direct holdings of 8,872 shares of common stock. A footnote also describes restricted stock units granted under the Agilent Technologies, Inc. 2018 Stock Plan, which vest in four equal annual installments beginning on May 19, 2027, in compliance with Rule 16b-3.
AGILENT TECHNOLOGIES, INC. President and CEO Padraig McDonnell reported a routine share disposition related to taxes. He surrendered 418 shares of common stock to Agilent to satisfy the tax liability on the vesting of restricted stock units, as allowed under Rule 16b-3. After this tax-withholding transaction, he holds 65,842 shares of Agilent common stock directly.
Agilent Technologies director Mikael Dolsten sold 1,600 shares of common stock in an open-market transaction at $135.42 per share. After this sale, he directly holds 5,548.385 shares. This balance includes 10.175 shares acquired through Agilent’s dividend reinvestment plan, which he has elected to defer.
Agilent Technologies reported stronger quarterly results with solid growth and profitability. For the three months ended April 30, 2026, net revenue rose to $1.835 billion from $1.668 billion, driven by higher product and service sales across Life Sciences and Diagnostics, Agilent CrossLab, and Applied Markets. Net income increased to $339 million from $215 million, with diluted EPS of $1.20 versus $0.75 a year earlier.
For the first six months of fiscal 2026, revenue reached $3.633 billion and net income $644 million. Agilent ended the quarter with $1.807 billion in cash and cash equivalents and total assets of $13.065 billion, against total liabilities of $5.943 billion. The company announced a pending acquisition of Biocare for approximately $950 million in cash, continued its 2024 share repurchase program, and paid dividends of $0.510 per share year-to-date while maintaining significant borrowing capacity under its credit facilities and commercial paper program.
A submitted a Form 144 notice reporting proposed sales of Common Stock. The filing lists 1,600 shares (and a value field 216,672.00) plus three restricted stock vesting entries of 245, 910 and 445 shares with respective vesting dates 03/16/2023, 03/14/2025 and 03/19/2026.
Agilent Technologies reported strong second-quarter fiscal 2026 results, with revenue of $1.83 billion, up 10% year-over-year and 6.3% on a core basis. GAAP net income was $339 million, or $1.20 per share, up 60% from the prior-year quarter, while non-GAAP EPS rose 14% to $1.49.
All segments grew, led by Applied Markets up 14% and Life Sciences and Diagnostics up 12%. The company raised its full-year 2026 outlook, guiding revenue to $7.39–$7.49 billion and non-GAAP EPS to $6.00–$6.10, and issued Q3 revenue guidance of $1.83–$1.85 billion. Agilent also named Tim Downs as Vice President and Chief Accounting Officer, with a $400,000 base salary, 60% target bonus, a $175,000 cash sign-on bonus, and a $1.0 million RSU grant vesting over four years.
Buckner Michael Steven reported acquisition or exercise transactions in this Form 4 filing.
AGILENT TECHNOLOGIES, INC. Senior Vice President Michael Steven Buckner received an equity compensation award reported on Form 4. He was granted 8,872 restricted stock units under the Agilent Technologies, Inc. 2018 Stock Plan, with no cash paid per unit.
The restricted stock units vest in four equal annual installments beginning on May 19, 2027, meaning the award will fully vest over four years if conditions are met. Following this grant, Buckner directly holds 8,887 shares of Agilent common stock, reflecting a relatively modest ownership position for a senior executive.
Agilent Technologies Senior Vice President Simon May surrendered 368 shares of common stock on May 8, 2026 at $115.62 per share to cover tax obligations on the vesting of restricted stock units. This was a tax-withholding disposition, not an open-market sale. After the transaction, May directly holds about 14,015.487 shares, which include 3.457 shares acquired through a dividend reinvestment plan and 172.7831 shares acquired through an employee stock purchase plan.